Acute Myeloid Leukemia (AML) Therapeutics Market Report

Global and China Acute Myeloid Leukemia (AML) Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 09, 2022
  • PAGES：168
  • REPORT CODE：GMM1357825
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Acute Myeloid Leukemia (AML) Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • GlaxoSmithKline Pharmaceuticals

    • Novartis

    • Genmab

    • Bristol-Myers Squibb

    • Roche

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Chemotherapy

    • Radiation therapy

    • Stem Cell Transplant

    • Targeted Therapy

    • Others

    Application:

    • Hospital

    • Retails Drug Stores

    • Ambulatory Care Centers

    • Oncology Centers

    • Clinics

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Acute Myeloid Leukemia (AML) Therapeutics Industry Overview

      • 1.1.1 Acute Myeloid Leukemia (AML) Therapeutics Market Scope and Market Segments

      • 1.1.2 Acute Myeloid Leukemia (AML) Therapeutics Industry Characteristics

      • 1.1.3 Global and China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Acute Myeloid Leukemia (AML) Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Chemotherapy

      • 1.2.2 Radiation therapy

      • 1.2.3 Stem Cell Transplant

      • 1.2.4 Targeted Therapy

      • 1.2.5 Others

    • 1.3 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Retails Drug Stores

      • 1.3.3 Ambulatory Care Centers

      • 1.3.4 Oncology Centers

      • 1.3.5 Clinics

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Acute Myeloid Leukemia (AML) Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Acute Myeloid Leukemia (AML) Therapeutics Industry PEST Analysis

    • 2.3 Acute Myeloid Leukemia (AML) Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Acute Myeloid Leukemia (AML) Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Acute Myeloid Leukemia (AML) Therapeutics Industry

    Chapter 3 Global and China Acute Myeloid Leukemia (AML) Therapeutics Market, by Manufacturer

    • 3.1 Global and China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Acute Myeloid Leukemia (AML) Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Acute Myeloid Leukemia (AML) Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Acute Myeloid Leukemia (AML) Therapeutics Market Top 3 Players

    Chapter 4 Global and China Acute Myeloid Leukemia (AML) Therapeutics Market, by Type (2017-2028)

    • 4.1 Acute Myeloid Leukemia (AML) Therapeutics Market Trend, by Type

    • 4.2 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Acute Myeloid Leukemia (AML) Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Acute Myeloid Leukemia (AML) Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Acute Myeloid Leukemia (AML) Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Acute Myeloid Leukemia (AML) Therapeutics Market Analysis

    • 7.1 North America Acute Myeloid Leukemia (AML) Therapeutics Market, by Type

    • 7.2 North America Acute Myeloid Leukemia (AML) Therapeutics Market, by Application

    • 7.3 North America Acute Myeloid Leukemia (AML) Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Analysis

    • 8.1 Europe Acute Myeloid Leukemia (AML) Therapeutics Market, by Type

    • 8.2 Europe Acute Myeloid Leukemia (AML) Therapeutics Market, by Application

    • 8.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Acute Myeloid Leukemia (AML) Therapeutics Market Analysis

    • 9.1 APAC Acute Myeloid Leukemia (AML) Therapeutics Market, by Type

    • 9.2 APAC Acute Myeloid Leukemia (AML) Therapeutics Market, by Application

    • 9.3 APAC Acute Myeloid Leukemia (AML) Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Acute Myeloid Leukemia (AML) Therapeutics Company Profiles

      • 11.1 GlaxoSmithKline Pharmaceuticals

        • 11.1.1 GlaxoSmithKline Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Product Profiles, Application and Specification

        • 11.1.3 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Novartis

        • 11.2.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Novartis Acute Myeloid Leukemia (AML) Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Novartis Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Genmab

        • 11.3.1 Genmab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Genmab Acute Myeloid Leukemia (AML) Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Genmab Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bristol-Myers Squibb

        • 11.4.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Roche

        • 11.5.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Roche Acute Myeloid Leukemia (AML) Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Roche Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Acute Myeloid Leukemia (AML) Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Acute Myeloid Leukemia (AML) Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Acute Myeloid Leukemia (AML) Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Chemotherapy (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Radiation therapy (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Stem Cell Transplant (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Targeted Therapy (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Retails Drug Stores (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Ambulatory Care Centers (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Oncology Centers (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Market Size and Growth Rate of Clinics (2017-2028)

    • Figure North America Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Acute Myeloid Leukemia (AML) Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Acute Myeloid Leukemia (AML) Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Acute Myeloid Leukemia (AML) Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Acute Myeloid Leukemia (AML) Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Price Trend, by Type (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Value, by Type (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Acute Myeloid Leukemia (AML) Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Value, by Application (2017-2028)

    • Table China Acute Myeloid Leukemia (AML) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Acute Myeloid Leukemia (AML) Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Acute Myeloid Leukemia (AML) Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table GlaxoSmithKline Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Pharmaceuticals Product Profiles, Application and Specification

    • Table GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genmab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genmab Product Profiles, Application and Specification

    • Table Genmab Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Acute Myeloid Leukemia (AML) Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US